FMP
iTeos Therapeutics, Inc.
ITOS
NASDAQ
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
10.57 USD
-0.42 (-3.97%)
About
ceo
Dr. Michel Detheux Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.iteostherapeutics.com
exchange
NASDAQ
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachuset...
CIK
0001808865
ISIN
US46565G1040
CUSIP
46565G104
Address
321 Arsenal Street
Phone
339 217 0161
Country
US
Employee
157
IPO Date
Jul 24, 2020
Summary
CIK
0001808865
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
46565G104
ISIN
US46565G1040
Country
US
Price
10.57
Beta
1.19
Volume Avg.
279.51k
Market Cap
378.86M
Shares
-
52-Week
8.2-18.24
DCF
7.13
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-3.36
P/B
-
Website
https://www.iteostherapeutics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ITOS News
It looks like there's no news available.
